Anastazja Szlauer-Stefanska, MD, PhD

Bone Marrow Transplantation and Oncohematology Department, Maria Sklodowska-Curie National Research Institute of Oncology (branch in Gliwice),, Poland

Poster(s):

• 1406 - Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult Leukemia Group